CODE KENNETH REAY (Chief Science Officer) received a stock award from BIOLARGO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/7/2026ACC: 0001437749-26-022951
DirectorOfficer10% Owner· Chief Science Officer
Since Jul 2018
+532.57K
Net shares
Net buyer
$60.4K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
532.57K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+532.57K
Price / share
$0.11
Trade value
$60.45K
% of position
2.1%
7/7/2026
25.88M→26.41M
Total
Net shares
+532.57K
Net value
$60.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/7/2026 | A · Award | +532.57K | $0.11 | $60.45K | 2.1% | 25.88M | 26.41M |
| Total | +532.57K | $60.45K | ||||||
Derivative Transactions0
No derivative transactions reported